pI: 10.7345 |
Length (AA): 401 |
MW (Da): 43252 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
31 | 323 | 5a53 (C) | 23 | 252 | 32.00 | 0 | 1 | 0.757173 | 0.78 |
31 | 322 | 5by8 (A) | 23 | 253 | 34.00 | 0 | 0.98 | 0.75368 | 0.87 |
172 | 300 | 5lhj (A) | 36 | 163 | 32.00 | 0.88 | 0.05 | 0.439196 | 0.91 |
207 | 344 | 5cwk (A) | 26 | 162 | 18.00 | 0.36 | 0.21 | 0.57864 | -0.59 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Fritz HM Sibley/Greg |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_127909)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G23620 | ribosome production factor 2-like protein |
Babesia bovis | BBOV_I002810 | Brix domain containing protein |
Brugia malayi | Bm1_03295 | Brix domain containing protein 1 homolog |
Candida albicans | CaO19.11036 | brix domain protein similar to S. cerevisiae RPF2 (YKR081C) nucleolar protein involved in 60S ribosomal subunit biogenesis |
Candida albicans | CaO19.3553 | brix domain protein similar to S. cerevisiae RPF2 (YKR081C) nucleolar protein involved in 60S ribosomal subunit biogenesis |
Caenorhabditis elegans | CELE_Y54E10A.10 | Protein Y54E10A.10 |
Cryptosporidium hominis | Chro.80539 | hypothetical protein |
Cryptosporidium parvum | cgd8_4680 | conserved protein; Py hit 23481194 |
Dictyostelium discoideum | DDB_G0292216 | brix domain-containing protein |
Drosophila melanogaster | Dmel_CG7993 | Novel nucleolar protein 3 |
Echinococcus granulosus | EgrG_000581200 | ribosome production factor 2 |
Entamoeba histolytica | EHI_029200 | ribosome biogenesis protein, putative |
Echinococcus multilocularis | EmuJ_000581200 | ribosome production factor 2 |
Giardia lamblia | GL50803_6835 | Brix domain containing protein |
Homo sapiens | 84154 | ribosome production factor 2 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.26.0030 | brix domain containing-like protein |
Leishmania donovani | LdBPK_260020.1 | brix domain containing-like protein |
Leishmania infantum | LinJ.26.0020 | brix domain containing-like protein |
Leishmania major | LmjF.26.0010 | brix domain containing-like protein |
Leishmania mexicana | LmxM.26.0010a | |
Leishmania mexicana | LmxM.26.0010 | brix domain containing-like protein |
Loa Loa (eye worm) | LOAG_10304 | brix domain-containing protein 1 |
Mus musculus | ENSMUSG00000038510 | ribosome production factor 2 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_032490 | brix domain-containing protein, putative |
Oryza sativa | 4323989 | Os01g0513800 |
Onchocerca volvulus | OVOC109 | Ribosome production factor 2 homolog |
Plasmodium berghei | PBANKA_0512500 | nucleolar preribosomal assembly protein, putative |
Plasmodium falciparum | PF3D7_1028400 | nucleolar preribosomal assembly protein, putative |
Plasmodium knowlesi | PKNH_0612800 | BRIX domain, putative |
Plasmodium vivax | PVX_111300 | brix domain containing protein |
Plasmodium yoelii | PY05510 | hypothetical protein |
Saccharomyces cerevisiae | YKR081C | Rpf2p |
Schistosoma japonicum | Sjp_0009340 | Brix domain-containing protein 1, putative |
Schistosoma mansoni | Smp_028340 | brix domain containing protein |
Schmidtea mediterranea | mk4.000172.22 | Ribosome production factor 2 homolog |
Trypanosoma brucei gambiense | Tbg972.7.150 | ribosome biogenesis protein, putative |
Trypanosoma brucei | Tb927.7.270 | Ribosome production factor 2 homolog |
Trypanosoma congolense | TcIL3000_7_70 | ribosome biogenesis protein, putative |
Trypanosoma cruzi | TcCLB.506413.70 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.511237.100 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_232520 | brix domain-containing protein |
Theileria parva | TP01_0566 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_093310 | brix domain containing protein, putative |
Trichomonas vaginalis | TVAG_467320 | brix domain containing protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.270 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.270 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.270 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.270 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y54E10A.10 | Caenorhabditis elegans | slow growth | wormbase |
YKR081C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_232520 this record | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.